Gilead’s twice-yearly medication shows success in preventing HIV, but cost criticized by Luke Zarzecki, Inside Health Policy | Jul 25, 2024
Advocates: Replacement needed as HHS ends free PrEP program by Luke Zarzecki, Inside Health Policy | Jul 24, 2024
Federal HIV program set to wind down by Alice Miranda Ollstein and David Lim, Politico Pro | Jul 23, 2024
Updated CMS guidance on long-acting PrEP needed, advocates say by Luke Zarzecki, Inside Health Policy | Jul 18, 2024
White House urged to expand PrEP coverage for injectable form by Troy Masters, Washington Blade | Jul 18, 2024
